Beginnings of Personalized Medicine for Myeloma
Ajai Chari, MD
Video Categories: Personalized Medicine
Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.
Dr Hope Rugo discusses some of the choices and challenges she’s faced with in treating patients with HR+/ HER2-negative metastatic breast cancer with the goal of helping patients live as long as possible and with the best quality of life.